Covidien (COV) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Income from continuing operations before income taxes: 583M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income from continuing operations before income taxes: 583M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q3 EPS of $1.01, $0.06 better than the analyst estimate of $0.95. Revenue for the quarter came in at $2.93 billion versus the consensus estimate of $2.86 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Avnet (AVT) Tops Q1 EPS by 97c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
